Underutilization of pancreatic enzyme replacement therapy in pancreatic cancer and chronic pancreatitis

PERTurbations in the pancreas

“…The paper by Kumar et al. in this issue of the Journal of Internal Medicine takes a bird eye's view screening a database of 74 million individuals, matching 20,700 chronic pancreatitis and pancreatic cancer patients with the prescription of pancreatic enzymes—which only 27% of them received [3]. Given the incidence of PEI in chronic pancreatitis and pancreatic cancer, at least 50% will be in need for PERT [4].…”